ClinicalTrials.govpublic full text
Study to Investigate the Efficacy, Safety and Tolerability of AZD1152 Alone and in Combination With Low Dose Cytosine Arabinoside (LDAC)in Acute Myeloid Leukaemia (AML) Patients
acute myeloid leukemia, acute myeloid leukaemia,, aml, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1032079
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.